{"id":"W4395007321","doi":"10.1186/s13045-024-01542-9","title":"Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel","year":2024,"lang":"en","type":"letter","venue":"Journal of Hematology & Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institutes of Health; Incyte; TG Therapeutics; National Cancer Institute; Laffey-McHugh Foundation; Pharmacyclics; Genentech; Celgene; Mallinckrodt Pharmaceuticals; Society for Immunotherapy of Cancer; University of Pennsylvania; Gilead Sciences; Leukemia and Lymphoma Society","keywords":"Bendamustine; Medicine; Cytokine release syndrome; Internal medicine; Fludarabine; Cyclophosphamide; Gastroenterology; Lymphoma; Immunotherapy; Rituximab; Chemotherapy; Cancer; Chimeric antigen receptor","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00129292,0.0003767709,0.002628814,0.0009291803,0.00005996816,0.00001165286,0.000274333,0.001960589,0.000944143],"category_scores_gemma":[0.0005271291,0.0002956726,0.0005908001,0.0002181797,0.000543031,0.00004781123,0.0001366551,0.002435585,0.00001257384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000506928,"about_ca_system_score_gemma":0.001308847,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001028488,"about_ca_topic_score_gemma":0.00001828693,"domain_scores_codex":[0.9966465,0.0002899197,0.001628425,0.0004021432,0.0004638901,0.0005691197],"domain_scores_gemma":[0.996044,0.001616083,0.001113001,0.0003581073,0.0007051632,0.0001636615],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008101726,0.0003125225,0.0008073787,0.003866029,0.002080233,0.00675065,0.0003760271,0.000001668185,0.006693119,0.00024406,0.9442529,0.02651368],"study_design_scores_gemma":[0.008551951,0.007830099,0.0007797737,0.0007160479,0.001401399,0.04348866,0.00005013025,0.00004368586,0.001018571,0.0006618524,0.9352888,0.0001690486],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.09233999,0.01109858,0.0004129355,0.8909546,0.002077613,0.001551444,0.0001049317,0.00003168557,0.001428262],"genre_scores_gemma":[0.07211879,0.0153716,0.03780923,0.7506124,0.04548056,0.0003557627,0.001603482,0.001389587,0.07525863],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.1403422,"threshold_uncertainty_score":0.9999691,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03244576333228277,"score_gpt":0.3624544389628308,"score_spread":0.330008675630548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}